PMFLIST Archives

May 2006

PMFLIST@LISTS.MICROBIOLOGYNETWORK.COM

Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Joseph Kirby Farrington <[log in to unmask]>
Reply To:
The Pharmaceutical Microbiology Forum Email List <[log in to unmask]>
Date:
Tue, 30 May 2006 13:38:40 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (77 lines)
Yes---  THE EMPEROR HAS NO CLOTHES- published studies show the methods in 
general do not have the capabilities many of us wish that they did. 
However, the methods are the methods. Specifications/requirements are tied 

to the methods (or should be). We (the pharmaceutical industry) are 
required to have adequate control over microorganisms in our respective 
products. If the user does not believe that they have adequate control 
they should do something to achieve what they would consider adequate 
control. There are provisions for using alternative methods (USP <1223>). 
It should not be hard to show that a "good method" is equal to or better 
than a "bad" method in detecting microbial contaminants. i.e the good 
method picks up everything the bad method does and then some. There is no 
method that will pick up every single contaminant or potential 
contaminant. As has been pointed out repeatedly, paradigms have worked 
their way into many guidelines and regulations. This took time. It will 
take time to get them out.The more published information "out there" 
preferably in refereed journals the more ammunition regulators and 
industry have to work with. As we all know, it can take very little effort 

to get a paradigm into a guideline, regulation or SOP but the proverbial 
"act of God" to get it out. This is now the era of scientific proof for 
methods and specifications- this proof works both directions i.e it 
(method) works or it does not work. Unfortunately,saying something does 
not work is not proof and cannot be acted upon.

The usual disclaimer- I speak for myself.

Kirby

J. Kirby Farrington, Ph.D. (RM/SM) NRM
Specialist Microbiologist-ASCP
Research Advisor-Microbiology and Sterility Assurance
Eli Lilly  Indianapolis  46285
Lilly LTC   Mail Stop 5546
317-651-9620  Beep.256-2840 cell 317-430-6548

------------------
The PMFList (http://microbiol.org/PMFList_info.htm) is operated from
The Microbiology Network (http://microbiol.org) and supported by
our sponsors (http://microbiol.org/sponsor.htm) as a service to
the scientific community.

Please take a second to visit our sponsors' web sites and say thank you for their support of this service.

Accugenix - http://www.accugenix.com

American Type Culture Collection - http://www.atcc.org

ATS Laboratories - http://www.ats-labs.com

Biolog - http://www.biolog.com

Biomerieux - http://industry.biomerieux-usa.com

Dupont Qualicon - http://www.qualicon.com

EMD Chemicals - http://www.emdchemicals.com

EMSL Analytical, Inc. - http://www.emsl.com

Genomic Profiling Systems, Inc. - http://www.genprosys.com

MIDI, Inc. - http://www.midi-inc.com

Millipore - http://www.millipore.com

Pall - http://www.pall.com

NovaTek International - http://www.ntint.com

Raven Biological Labs - http://www.ravenlabs.com

Veltek Associates, Inc - http://www.sterile.com

=================================
The nature of this service is to provide a medium for communication.  The specific statements and endorsements of individuals participating in the discussions are not necessarily those of The Microbiology Network, Inc., the PMF, or the sponsors of the list.

ATOM RSS1 RSS2